Zifam CS1/CS2

Zifam CS1/CS2 Warnings

cefoperazone + sulbactam

Manufacturer:

Zifam Pinnacle

Distributor:

Pyrex
Full Prescribing Info
Warnings
Seriously and occasionally, hypersensitivity (anaphylactic) reactions have been reported in patients receiving β-lactam therapy. These reactions are more apt to occur in individuals with history of hypersensitivity reactions to multiple allergens. If any allergic reaction occurs, the drug should be discontinued and the appropriate therapy instituted. Serious anaphylactic reactions require immediate emergency treatment with epinephrine, oxygen, IV steroids and airway management, including intubation, should be administered as indicated.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in